Kidney Failure News and Research

RSS

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients

The ASUNCTIS trial evaluated asunercept's safety and efficacy in COVID-19, showing trends toward faster recovery despite not meeting statistical significance.

18 Nov 2024

Global gap in diabetes prevalence and treatment has widened since 1990

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and highlighting the need for improved care.

15 Nov 2024

New research reveals how Hepatitis E virus can lead to kidney disease

The hepatitis E virus affects the liver. But infected liver cells secrete a viral protein that reacts with antibodies in the blood and may form complexes that can damage the filter structure of the kidneys, as researchers from the University of Zurich and the University Hospital Zurich have proven for the first time.

1 Nov 2024

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Researchers investigate the clinical efficacy of semaglutide in controlling urine albumin-to-creatinine ratio in overweight patients with chronic kidney disease.

31 Oct 2024

Could vitamin D be the missing link in managing type 2 diabetes? Recent study weighs in

Vitamin D's role in type 2 diabetes management is evolving, with evidence suggesting it may improve blood sugar levels and reduce diabetes-related inflammation.

29 Oct 2024

NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients

The National Institutes of Health awarded a four-year, $2.6 million grant to researchers at Case Western Reserve University to study how high blood-pressure drugs affect patients with chronic kidney disease (CKD).

28 Oct 2024

Elucidating the mechanisms behind kidney development

To Alex Hughes, Assistant Professor in Bioengineering within Penn Engineering and in Cell and Developmental Biology within Penn Medicine, the kidney is a work of art. "I find the development of the kidney to be a really beautiful process," says Hughes.

28 Oct 2024

How a proposed federal heat rule might have saved these workers’ lives

On a sweltering afternoon in July 2020, Belinda Ramones got a call that her brother was in the hospital. The call was from a woman at the Florida landscaping business that he had joined that week, the Davey Tree Expert Co., Ramones said. By the time she arrived, she said, "My brother was swollen up from hands to toes."

28 Oct 2024

Ozempic effective for patients with chronic kidney damage

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic kidney disease and obesity.

28 Oct 2024

Researchers identify cause and potential therapeutic approach for diabetic kidney disease

Diabetic kidney disease – a complication of diabetes – is considered the leading cause of chronic kidney disease and kidney failure worldwide.

10 Oct 2024

Diagnostic errors affecting one in fourteen hospital patients

Harmful diagnostic errors may be occurring in as many as 1 in every 14 (7%) hospital patients - at least those receiving general medical care - suggest the findings of a single center study in the US, published online in the journal BMJ Quality & Safety.

1 Oct 2024

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals of Surgery.

20 Sep 2024

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

The Lupus Research Alliance (LRA) is pleased to announce the recipients of the 2024 Career Development and Postdoctoral Awards to Promote Diversity in Lupus Research.

17 Sep 2024

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don't have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept).

13 Sep 2024

Breakthrough research identifies key microenvironments linked to kidney injury and disease

A study published in Nature Communications provides new insight into how damaged cells interact within disease-promoting microenvironments following acute kidney injury, or AKI.

5 Sep 2024

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

A pooled analysis of three large trials failed to demonstrate significant reductions in cardiovascular death with finerenone, but significantly lower all-cause mortality, cardiovascular events and kidney outcomes were observed, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

2 Sep 2024

Kidney Failure News and Research

Phase 2 study evaluates safety and efficacy of asunercept in COVID-19 patients

Global gap in diabetes prevalence and treatment has widened since 1990

New research reveals how Hepatitis E virus can lead to kidney disease

Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients

Could vitamin D be the missing link in managing type 2 diabetes? Recent study weighs in

NIH grants $2.6 million to explore the effects of high blood-pressure drugs in CKD patients

Elucidating the mechanisms behind kidney development

How a proposed federal heat rule might have saved these workers’ lives

Ozempic effective for patients with chronic kidney damage

Researchers identify cause and potential therapeutic approach for diabetic kidney disease

Diagnostic errors affecting one in fourteen hospital patients

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

Research highlights cardiovascular benefits of semaglutide for overweight adults with impaired kidney function

Breakthrough research identifies key microenvironments linked to kidney injury and disease

Pooled analysis shows finerenone reduces all-cause mortality but not cardiovascular death

Understanding the benefits and risks of dialysis in older patients with kidney failure

Artificial intelligence predicts tongue disease with 96 percent accuracy

Long-term immune changes persist in unvaccinated COVID-19 patients

NYU Langone Health earns No. 1 spot in neurology and neurosurgery for the third straight year

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News